Intimation of investor meeting.
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech has informed the stock exchanges that company officials will participate in investor meetings on December 8, 2025, in Mumbai. The meetings will be conducted physically and will include both one-to-one and group sessions. The company clarified that the discussions will be based on the unaudited financial results for the half year ended September 30, 2025, which were already released on November 11, 2025, along with a publicly available investor presentation. The company has stated that no unpublished price-sensitive information (UPSI) will be shared during these meetings. Both the press release and investor presentation are available on the company's website and BSE's website.
This is a routine compliance disclosure and does not signal any new corporate action. Investors can expect management commentary on H1 FY26 results, but no fresh information is likely to be shared beyond what is already public.